CoChat

Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes

Open access
Majewski, Colleen, Bakris, George L. · 2015 · Diabetes Care
Cited by 115

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Sodium–glucose cotransporter 2 (SGLT2) inhibitors are a newly approved class of glucose-lowering medications with a novel mechanism of action. These agents increase glycosuria, which leads to improved glucose control. They also produce an osmotic diuresis that, in part, contributes to blood pressure reduction and calorie loss secondary to glycosuria leading to weight loss (1,2). A recent review of SGLT2 inhibitors focuses on the blood pressure–lowering effects of the two approved glucose-lowering agents, dapagliflozin and canagliflozin (3). While not approved as antihypertensive agents, they may potentially aid in lowering blood pressure in patients with diabetes. A review of studies in both hypertensive and normotensive patients with type 2 diabetes demonstrates a 4–10 mmHg reduction of systolic blood pressure (3). In this issue of Diabetes Care , Tikkanen et al. (4) investigate the effectiveness and safety of the newest agent in this class, empagliflozin, on blood pressure using 24-h ambulatory blood pressure monitoring. This study randomized over 800 subjects with type 2 diabetes, mean age of 60 years, and good kidney function (i.e., a mean estimated glomerular filtration rate [eGFR] of 84 mL/min/1.73 m2). These subjects either were normotensive (<140/90 mmHg) or had stage 1 hypertension (≥140/90 < 160/99 mmHg). They were randomized to either empagliflozin 10 mg daily, empagliflozin 25 mg …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc14-1596

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 115

Metadata

Authors
Majewski, C., & Bakris, G. L.
Venue
Diabetes Care
Published
2015-02-12
Volume
38
Issue
3
Pages
429-430
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2127413863
Cited by
115
References
2
FWCI
11.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.